AFG-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAFG-2
Drug Alias Nameanti-VEGF Nanofitins (Affilogic)AFG-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffilogic Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffilogic Laboratories
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A